Across TCGA pan-cancer cohorts, GLP1R RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of GLP1R’s most consistent transcriptional readouts.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where GLP1R RNA is more highly expressed in tumor relative to normal tissue. In most cancer types GLP1R is over-expressed in tumor, although a few such as LUSC and KICH show the opposite, repressed pattern.
UCEC, LUSC, and KICH are the cancer types where GLP1R tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GLP1R RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.